Patent & Trade Mark

South East Asia

Currently the ASEAN IP Rights (IPR) Action plan is being implemented, with the aim of improving and harmonising IP Regimes across the region. The pace of change is slow, but the Action Plan provides an impetus for ongoing reform.

For information on individual countries, please follow the links below.

South East Asia publications
20 Sep 2016
Interested in learning more about the IP agreement membership status of various member states? We've got you covered.

06 Sep 2016
Monoclonal antibodies are important human therapeutic agents and represent some of the largest selling drugs in the world. Patents relating to antibodies are treated differently to some other compounds in some jurisdictions. This article touches on some of the important requirements for antibody patenting in some major Asian jurisdictions, namely Japan, China and South Korea.